HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.400
-0.039 (-8.88%)
At close: Apr 28, 2026, 4:00 PM EDT
0.391
-0.009 (-2.25%)
After-hours: Apr 28, 2026, 7:59 PM EDT

HCW Biologics Statistics

Total Valuation

HCW Biologics has a market cap or net worth of $2.69 million. The enterprise value is $7.51 million.

Market Cap 2.69M
Enterprise Value 7.51M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date May 14, 2026
Ex-Dividend Date n/a

Share Statistics

HCW Biologics has 6.73 million shares outstanding. The number of shares has increased by 116.30% in one year.

Current Share Class 6.73M
Shares Outstanding 6.73M
Shares Change (YoY) +116.30%
Shares Change (QoQ) +49.73%
Owned by Insiders (%) 9.41%
Owned by Institutions (%) 1.99%
Float 6.10M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 48.95
Forward PS n/a
PB Ratio 0.52
P/TBV Ratio 0.96
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 138.50
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.11, with a Debt / Equity ratio of 2.46.

Current Ratio 0.11
Quick Ratio 0.09
Debt / Equity 2.46
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -16.17

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -31.19%
Return on Invested Capital (ROIC) -103.53%
Return on Capital Employed (ROCE) -395.18%
Weighted Average Cost of Capital (WACC) 9.64%
Revenue Per Employee $1,506
Profits Per Employee -$619,408
Employee Count 36
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -94.20% in the last 52 weeks. The beta is 0.90, so HCW Biologics's price volatility has been similar to the market average.

Beta (5Y) 0.90
52-Week Price Change -94.20%
50-Day Moving Average 0.50
200-Day Moving Average 2.43
Relative Strength Index (RSI) 45.68
Average Volume (20 Days) 2,102,093

Short Selling Information

The latest short interest is 130,618, so 1.94% of the outstanding shares have been sold short.

Short Interest 130,618
Short Previous Month 110,641
Short % of Shares Out 1.94%
Short % of Float 2.14%
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, HCW Biologics had revenue of $54,232 and -$22.30 million in losses. Loss per share was -$10.63.

Revenue 54,232
Gross Profit 10,846
Operating Income -13.66M
Pretax Income -7.96M
Net Income -22.30M
EBITDA -12.62M
EBIT -13.66M
Loss Per Share -$10.63
Full Income Statement

Balance Sheet

The company has $1.95 million in cash and $6.81 million in debt, giving a net cash position of -$4.86 million or -$0.72 per share.

Cash & Cash Equivalents 1.95M
Total Debt 6.81M
Net Cash -4.86M
Net Cash Per Share -$0.72
Equity (Book Value) 2.76M
Book Value Per Share 0.84
Working Capital -18.78M
Full Balance Sheet

Cash Flow

Operating Cash Flow -13.39M
Capital Expenditures n/a
Depreciation & Amortization 1.04M
Net Borrowing 22,377
Free Cash Flow -13.39M
FCF Per Share -$1.99
Full Cash Flow Statement

Margins

Gross Margin 20.00%
Operating Margin -25,192.71%
Pretax Margin -14,677.14%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HCW Biologics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -116.30%
Shareholder Yield -116.30%
Earnings Yield -840.01%
FCF Yield -504.47%

Analyst Forecast

The average price target for HCW Biologics is $35.00, which is 8,650.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $35.00
Price Target Difference 8,650.00%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 552.67%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on April 11, 2025. It was a reverse split with a ratio of 1:40.

Last Split Date Apr 11, 2025
Split Type Reverse
Split Ratio 1:40

Scores

HCW Biologics has an Altman Z-Score of -8.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.67
Piotroski F-Score 1